Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer
Apply
Toripalimab
Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step